ANG Lifesciences India Ltd. benchmarking: Performance to industry peers

Financial

	ANG Lifesciences	Sandu Pharmaceutical	Lasa Supergenerics
Operational Metrics
Financials
5 yr Average ROE	12.03 %	3.72 %	3.38 %
5yr average Equity Multiplier	3.3	1.33	1.44
5yr Average Asset Turnover Ratio	0.77	1.23	0.77
5yr Avg Net Profit Margin	-2.26 %	2.27 %	-8.22 %
Price to Book	0.61	0.88	0.67
P/E	0.0	23.94	0.0
5yr Avg Cash Conversion Cycle	70.26 Days	48.49 Days	11.27 Days
Inventory Days	107.37 Days	74.6 Days	46.83 Days
Days Receivable	274.82 Days	26.14 Days	10.61 Days
Days Payable	235.98 Days	72.73 Days	83.41 Days
5yr Average Interest Coverage Ratio	1.81	28.2	-18.91
5yr Avg ROCE	15.08 %	5.33 %	1.03 %
5yr Avg Operating Profit Margin	7.68 %	3.77 %	9.99 %
5 yr average Debt to Equity	0.97	0.0	0.2
5yr CAGR Net Profit	n/a	0.39 %	n/a
5yr Average Return on Assets	1.04 %	2.79 %	-5.59 %
Shareholdings
Promoter Holding	70.6 %	37.79 %	53.65 %
Share Pledged by Promoters	44.88 %	0.0	20.66 %
Change in Promoter Holding (3 Yrs)	0.0	-14.62 %	9.87 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0